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The term foodborne disease encompasses a
variety of clinical and etiologic conditions and
describes a subset of enteric disease (1-4), which
in the United States ranks second in prevalence to
respiratory disease (2). In foodborne disease, the
food may act as a vehicle for the transmission of
actively growing microorganisms or products of
metabolism (toxins), or it may have a passive role
as a vehicle for the transmission of nonreplicating
bacteria, viruses or protozoa, or stable biologic
toxins. In most cases, the clinical conditions
usually associated with foodborne disease are
acute: diarrhea, vomiting, or other gastrointesti-
nal manifestations such as dysentery. However,
other pathophysiologic responses may occur
independently or accompany acute-phase re-
sponses (1-4). A number of chronic sequelae may
result from foodborne infections, including
ankylosing spondylitis, arthropathies, renal
disease, cardiac and neurologic disorders, and
nutritional and other malabsorptive disorders
(incapacitating diarrhea). The evidence that
microorganisms or their products are either
directly or indirectly associated with these long-
term sequelae ranges from convincing to
circumstantial (1-4). The reason for this disparity
is that, except in rare circumstances, chronic
complications are unlikely to be identified or
epidemiologically linked to a foodborne cause
because these data are not systematically
collected. Moreover, host symptoms induced by a
specific pathogen or product of a pathogen are
often wide-ranging and overlapping and therefore
difficult to link temporally to a specific incident.
These impediments manifest themselves because
the problems associated with chronic disease can
result from an infection without overt illness.
Alternatively, the chronic sequelae may be
unrelated to the acute illness and may occur even
if the immune system successfully eliminates the
primary infection; therefore, activation of the
immune system may initiate the chronic
condition as a result of an autoimmune response
(2-4). The variability of the human response—
from overt illness to chronic carrier status—is
perhaps the most confounding issue.
Cost of Chronic Sequelae
As the incidence of foodborne disease
increases, the incidence of chronic sequelae
may also rise. Several authors have estimated
that chronic sequelae may occur in 2% to 3% of
foodborne disease cases and suggest that the
long-term consequences to human health and
the economy may be more detrimental than the
acute disease. An estimated 80 million cases of
foodborne disease occur annually in the United
States, which suggests significant morbidity
figures and costs to society in the billions of
dollars per year (2,4).
Infection: The Microbe/Toxin
versus the Host
Several microbial pathogens are highly
adapted to parasitization, exhibiting environmen-
tally responsive and adaptive traits that allow
attachment, invasion, and replication in the host
(2,4). Microbial pathogenicity can be viewed solely
from the perspective of the microbe; however, this
would be not only unidimensional, but also wrong
(2,4). A major selective force that regulates the
phenotype of an infecting microbial pathogen
population is the host’s immune system, which is
also highly adaptive, especially in discriminating
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self and nonself antigens (2,4). When the host-
parasite relationship is examined holistically,
mechanisms that successful pathogens have
apparently evolved to elude the immune system
include antigenic heterogeneity or variation;
sequestration, either intracellularly or in certain
specific host sites; molecular mimicry, through
either imitation (cross-reaction) or adsorption of
host protein; and direct immune stimulation and/
or suppression (2-5).
Rheumatoid Disease
Several bacteria, including salmonellae,
induce septic arthritis by hematogenous spread to
the synovial space, causing inflammation. Viable
organisms are recoverable from synovial fluid,
and treatment usually involves antibiotic therapy.
Prognosis depends on host factors and virulence of
the organism; either complete resolution or
permanent joint damage can occur (1-4,6,7).
Yersinia enterocolitica, Y. pseudotuberculo-
sis, Shigella flexneri, Sh. dysenteriae, Salmonella
spp., Campylobacter jejuni, and Escherichia coli
initiate aseptic or reactive arthritis, an acute,
nonpurulent joint inflammation following infec-
tion elsewhere in the body, for example the bowel.
Klebsiella pneumoniae has been implicated,
although it appears now that the bacterium is
connected with fecal carriage by ankylosing
spondylitis probands (4). Although a distinct
clinical disease, reactive arthritis also occurs in
the Reiter syndrome triad with conjunctivitis and
uveitis. A subset of patients with symptoms of
reactive arthritis and Reiter syndrome get
ankylosing spondylitis, a rheumatoid inflamma-
tion of synovial joints and entheses within and
distal to the spine (8).
The relative risk of developing these
seronegative spondyloarthropathies after a gram-
negative enterobacterial infection is high for
persons positive for the major histocompatibility
class (MHC) antigen B27 and the cross-reacting
MHC B7 group. Indeed, persons who are human
leukocyte antigen (HLA)-B27 positive have an 18-
fold greater risk for reactive arthritis, a 37-fold
greater risk for Reiter syndrome, and up to a 126-
fold greater risk for ankylosing spondylitis than
persons who are HLA-B27 negative and have the
same enteric infections. Other genes that may be
related or act in concert appear to determine
which disease is acquired (2,5,7,9). These chronic
complications are related to a genetically
determined host risk factor in combination with
an environmental trigger. No cause-and-effect
relationship of enteric pathogens in ankylosing
spondylitis has been established (4); however, a
low but consistent incidence (0.2% to 2.4%) of
reactive arthritis occurs after outbreaks of S.
Typhimurium, Sh. flexneri, and C. jejuni.
Biotypes and phage types of Y. enterocolitica O:3
and O:9, endemic to Scandinavia, are either highly
arthritogenic or affect a more genetically predis-
posed population with persistent and debilitating
symptoms that may last for years (2,3).
The sharing of antigenic determinants by a
microbe and its host is a frequent natural
occurrence, and bacterial antigens from the
pathogens that directly cross-react with MHC
B27 have been demonstrated (6,9). Additionally,
the plasmid-mediated synthesis of bacterial B27
“modifying factor,” a protein that binds to and
subsequently alters the conformation of B27, has
been reported (10). In both of these models,
immune recognition of the foreign antigen leads to
an autoimmune anti-B27 response. Alternatively,
B27 may act nonimmunologically because dissemi-
nation of bacterial antigens to infected joints
stimulates a local T-cell inflammatory response.
Here, B27 may act as a receptor for bacteria or
antigens thereof, facilitating invasiveness from
mucosal surfaces in the gut (9). Indeed, transfected
B27 on the surface of mouse L cells reportedly can
alter bacterial invasion capability (11).
Despite the strong familial association related
to the MHC B27 gene, B27-negative persons are
known to become ill, albeit less often, but with
apparently equal severity, as shown by an
epidemiologic investigation of rheumatoid arthri-
tis following the 1985 S. Typhimurium gastroen-
teritis outbreak due to contaminated milk (4).
Autoimmune Thyroid Disease
Graves disease is an autoimmune disease
mediated by autoantibodies to the thyrotropin
receptor (12,13). The first indication that the
disease may be linked to infection was finding
antibody titers to Y. enterocolitica serotype O:3
suggestive of molecular mimicry in a majority of
patients with Graves disease. Several studies
have shown that two low molecular weight
envelope proteins of Yersinia contain epitopes
cross-reactive with the thyrotropin receptor. These
proteins are chromosomally encoded, exposed to
the surface of the bacterium, and produced by
both virulent and avirulent strains of Yersinia
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VW+ and WV-). In addition to autoantibody, a
suppressor cell dysfunction may be involved in
Graves disease (12,13). Severe hypothyroidism
may also result from chronic intestinal giardiasis
due to infection by Giardia lamblia; treatment
with metronidazole can result in complete
elimination of the parasite and recovery of regular
intestinal thyroid hormone absorption (14).
Inflammatory Bowel Disease
Inflammatory bowel disease is the collective
term for Crohn disease and ulcerative colitis.
While both infections are chronic inflammatory
diseases with histologic infiltrates of macroph-
ages and lymphocytes and a prolonged clinical
course, the primary clinical and pathologic effects
are gastrointestinal. The infections can be
difficult to differentiate because the symptoms
are often similar (15). The acute clinical
characteristics are diarrhea, abdominal pain, fever,
and weight loss; and the acute pathologic features
include a constant flux of neutrophils into inflamed
mucosa, eventually penetrating the epithelium into
the intestinal lumen. The chronic spontaneously
relapsing disorder exhibits many of the symptoms
of the acute state; however, this phase has an
average symptom duration of 3.2 years before
correct diagnosis. Abdominal abscesses are a
common and dangerous complication of Crohn
disease, while in ulcerative colitis, abdominal
perforations may lead to peritonitis. Crohn disease
involves the ileum or colon (anaerobes are
important), while ulcerative colitis appears
restricted to the colon (aerobes are important).
Nationality and familial associations suggest a
genetic predisposition for the disease (4,15).
Although the cause of inflammatory bowel
disease and the mechanism(s) for spontaneous
exacerbations and remissions are unknown, much
research has focused on transmissible agents,
including foodborne pathogens. An association
between bacterial L-forms and inflammatory
bowel disease has been sporadically reported,
with isolation of Pseudomonas, Mycobacterium,
Enterococcus fecalis, and E. coli from affected
tissue but not from appropriate controls. There is
considerable debate as to whether L-forms are
pathogenic in humans or persist in affected tissue.
Mycobacterium paratuberculosis, the caus-
ative agent of Johne disease in ruminants, may be
associated with Crohn disease through the
production of L-forms of the bacterium. Subclini-
cally infected cows shed M. paratuberculosis, and
the organism has been identified in pasteurized
milk by polymerase chain reaction specific for the
M. paratuberculosis insertion sequence IS900.
The pathogen model suggests that a susceptible
human neonate first contracts the organism after
ingesting commercial dairy products. This
invokes an antigen-poor (lacking a cell wall) L-
form that grows slowly and persists in the lamina
propria, stimulating a chronic low-grade inflam-
mation. The immune response increases in
severity over years without bacterial replication,
ultimately producing the pathologic features of
Crohn disease (15,16). Another model proposes an
autoimmune phenomenon mediated by alter-
ations in inflammatory cytokine profiles, possibly
as a result of infection (4).
Recent immunocytochemical techniques
demonstrated antigens to Listeria monocytogenes,
E. coli, and Streptococcus spp. in Crohn disease
tissues. Macrophages and giant cells
immunolabelled for antigen specific to these
organisms were found beneath ulcers, around
abscesses, along fissures, within the lamina
propria, in granulomas, and in germinal centers of
mesenteric lymph nodes (17).
Superantigens and Autoimmunity
In contrast to conventional antigens,
superantigens interact with the variable side of
the Vß chain of the T-cell receptor by recognizing
elements shared by a subset of T cells. Depending
on the type of interaction, recognition can have
different consequences, including proliferation
and expansion, suppression (clonal deletion), or,
alternatively, induction of prolonged unrespon-
siveness (anergy) or cell death (apoptosis) (18-21).
Superantigens from several foodborne bacteria
(e.g.,  Staphylococcus,  Streptococcus,  Yersinia,
and  Clostridium) have been isolated and
characterized. Many are thought to be associated
with several autoimmune disorders, for example,
rheumatic heart disease, rheumatoid arthritis,
multiple sclerosis, Graves disease, Sjogren
syndrome, autoimmune thyroiditis, psoriasis,
Kawasaki disease, Crohn disease, and insulin-
dependent diabetes mellitus (6,18-24).
Although it is accepted that superantigens
have a role in autoimmune disorders, the
acceptance is based on extensive animal model
studies (6,18-24) but limited human clinical
studies. In human diseases where superantigens
have been clearly demonstrated as the cause, for
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proliferation and T-cell receptor–mRNA up-
regulation have been observed, but the long-term
sequelae in terms of T-cell function are unknown
(22). Recent studies suggest that superantigens
may also cause an acute flare of a disease within
patients in remission from a preexisting
autoimmune disorder.
Renal Disease
After colitis caused by E. coli O157:H7 and
other enterohemorrhagic strains of E. coli,
hemolytic uremic syndrome develops in some
patients (1,2,25). The syndrome is characterized
by a triad of symptoms: acute renal failure,
thrombocytopenia, and microangiopathic
hemolytic anemia. Acute renal failure is the
leading cause of death in children, and
thrombocytopenia is the leading cause of death in
adults. Hemolytic uremic syndrome is a world-
wide problem that mirrors the distribution of E.
coli O157:H7 and other Shiga and Shiga-like
toxin–producing microorganisms. Outbreaks of
hemorrhagic colitis and subsequent cases of
hemolytic uremic syndrome have developed as a
result of various food vehicles. Besides O157:H7,
other Shiga-like toxin–producing E. coli,
Citrobacter, Campylobacter, Shigella, Salmo-
nella, and Yersinia have been linked to the
disorder (1,2,25,26).
The toxin-mediated damage to the kidneys
may not be limited to the glomerular endothelial
cells as once thought but may include the tubular
epithelial cells (26-28). Binding studies showed
the toxins to be specific for the glycosphingolipid
globotriaosylceramide (Gb3), which is present on
renal but not umbilical endothelial cells. This may
account for the differential sensitivity of renal
cells to toxin-induced damage, since Gb3 was
present in the glomeruli of infants under 2 years
of age but not in the glomeruli of adults. Thus, the
presence of Gb3 in the pediatric renal glomerulus
may be a risk factor for development of hemolytic
uremic syndrome (28). Characterization of the
Shiga toxin receptor has led to a potential
preventive treatment (4).
Neural and Neuromuscular Disorders
Guillain-Barré syndrome is a subacute,
acquired, inflammatory demyelinating
polyradiculoneuropathy that frequently occurs
after acute gastrointestinal infection. The disease
is characterized by alexia, motor paralysis with
mild sensory disturbances, and an acellular
increase in the total protein content in the
cerebrospinal fluid. The disease occurs worldwide
and is the most common cause of neuromuscular
paralysis. Cases have three dominant character-
istics: the predilection to nerve roots, mono-
nuclear infiltration of peripheral nerves, and
eventual demyelination (primary axonal degen-
eration) (29). Severe cases tend to occur in the
summer and have been linked to previous
infection with C. jejuni, although other enteric
pathogens may trigger the syndrome.
Some controversy exists regarding whether
Guillain-Barré syndrome is an autoimmune
disease. Although adequate data exist to classify
the syndrome as an autoimmune disease (four
major Rose-Witebsky criteria are almost com-
pletely met), the immunologic mechanisms at
work in Guillain-Barré syndrome triggered by C.
jejuni are likely to be complex (29-31). Studies of
the relationship between Guillain-Barré syn-
drome and C. jejuni support the hypothesis of
molecular mimicry, since peripheral nerves may
share epitopes with surface antigens of C. jejuni
(32). This has been supported by studies in which
anti-GM1 IgG antibodies recognized surface
epitopes on intact C. jejuni, and the reaction was
strain-specific for certain Penner serotypes.
There are inconclusive data with regard to
Guillain-Barré syndrome and HLA, although
some studies have shown a predilection for the
HLA-B35 haplotype (29-31). Cytokines may be
responsible for inducing the inflammatory
process and probably play a role in the response
leading to nerve demyelination. Complement has
a role in the process leading to nerve damage,
possibly through the production of activation
products, which lead to an increase in the
permeability of the blood nerve barrier, which
perpetuates the inflammation. Although Guillain-
Barré syndrome might be considered an
autoimmune response, it also serves as an
example of a disease with an infectious origin, a
disease that entails the integrated actions of both
humoral and cellular immunity.
Ciguatera poisoning is the most common
foodborne disease related to the consumption of
fin fish; this distinctive clinical syndrome is
characterized by a plethora of gastrointestinal,
neurologic, and sometimes cardiovascular fea-
tures (33,34). Two toxins are involved in toxicosis.
Ciguatoxin-1 (cig-1), the principal toxin, is a heat
stable, lipid-soluble polyether that is not
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eliminated by drying, salting, smoking, or
marinating. Cig-1 induces membrane depolariza-
tion in nerve and muscle tissue by opening
voltage-dependent sodium channels. A second
toxin, maitotoxin, is water-soluble and opens
calcium channels. The role of this second toxin in
the pathophysiology of the disease is less well
understood. The acute symptoms of the toxicosis
are varied and include paresthesia of the
extremities, circumoral paresthesia, reversal of
hot and cold sensations, dental pain, myalgias,
arthralgias, generalized pruritus, cranial nerve
dysfunction, and dysuria. Severe acute symptoms
require urgent care with parenteral atropine for
bradyarrhythmias. Mannitol is often adminis-
tered to counter the effect of the toxin on the
sodium channels; however, the mechanism of
action is unknown, and the therapy is useless
after 24 hours. Many of these symptoms may
remain chronic and are often misdiagnosed as
chronic fatigue syndrome, brain tumors, or
multiple sclerosis. The management of the
chronic symptoms is frustrating for the patient
and clinician. Interventions include amitrip-
tyline, tocaidine, or mexilitine to modulate
sodium channels in conjunction with calcium
channel blockers such as nifedipine. Antidepres-
sants such as Prozac also appear to be useful.
Patients with chronic symptoms frequently report
waxing and waning of symptoms. Activities such as
sexual intercourse and drinking alcohol signifi-
cantly exacerbate expression. Some women with
chronic symptoms report worsening during
menses. Mood levels, weather conditions, and
dietary constituents often exacerbate symptoms.
Some clinicians advocate a strict diet that avoids all
seafood, fish byproducts, nuts, and alcohol, and in
some cases, patients are asked to abstain from sex.
One distinctive feature in this toxicosis is that one
episode of ciguatera poisoning does not confer
immunity. In fact, it is likely to sensitize the patient
to otherwise subthreshold doses of toxin (33,34).
Amnesic shellfish poisoning is caused by
domic acid, a conjugate of kainic and glutamic
acid (35). In small quantities domic acid has an
excitatory effect, but in large amounts it is
neurotoxic. The toxicosis is first characterized by
gastrointestinal symptoms followed by neurologic
dysfunction. Severe cases may be prolonged and
chronic; sequelae include confusion with disorien-
tation, paucity of speech, lack of response to deep
pain due to blocking of receptors in the spinal
cord, autonomic nervous system dysfunction,
seizures, abnormal ocular movements, grimacing
posture, myoclonus, loss of reflexes, and coma.
Other prominent chronic sequelae include loss of
visual-spacial recall and mononeuropathies with-
out dementia, mimicking Alzheimer’s disease.
The toxicosis is particularly serious in the elderly,
and any deaths usually occur within this
population. Valium, calcium channel blockers,
phenobarbital, diazapam, thiobarbiturates, and
hypothermia are treatments for patients with
severe and chronic cases.
General Immunity, Organ Impairment, and
Neurologic Disorders
Toxoplasmosis due to Toxoplasma gondii is a
chronic latent parasitic infection (36,37). In
humans the parasite exists in two forms: the
tachyzoite, the rapidly multiplying stage that
actively invades host cells and represents the
principal form of the acute phase of the disease;
and the bradyzoite, the form that multiplies very
slowly in host cells, resulting in the formation of
cysts that persist in tissues. Toxoplasma infection
in humans is usually asymptomatic because of
effective immunity involving antibodies, T cells,
and cytokines. Activated macrophages, CD4 and
CD8 lymphocytes, and the cytokines IFN-g,
TNF-a, and IL-6 play a major role in control of
both the acute infection and maintenance or
prevention of the chronic stage (37,38). Indeed,
treatment with IFN-g is used to control passage
into the chronic stage, and treatment with anti-
IFN-g reactivates chronic infection (39). The
production of nitric oxide may have opposing
effects. Nitric oxide production protects against T.
gondii and at the same time limits the immune
response, probably contributing to the establish-
ment of the chronic state (40).
The incidence of congenital toxoplasmosis is
uncertain but may be as high as 9,500 cases a year
(1). The percentage attributable to food is
uncertain; however, consumption or contact with
contaminated meat is more important as a cause
than is contact with cats (1). Congenital
impairments associated with maternal toxoplas-
mosis infection passed to the fetus include
hearing loss, visual impairment (retinal lesions,
strabismus), and slight to severe mental
retardation. These impairments are still present
in 80% of persons who reach the age of 20 years
(1). Chronic toxoplasmic encephalitis may occur
when a person’s immune system is impaired.
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dementia and seizures has become the most
commonly recognized cause of central nervous
system opportunistic infections in AIDS patients.
Additionally, it appears that certain cancer
treatments weaken the immune system, and old
infections in the muscles can become reactivated,
causing severe complications or death (1,41,42).
Helminth parasites can cause serious disease
in infected persons (42). The impact of helminth
infections is due less to the severity of the diseases
they cause, than to the vast number of persons
infected. For example, more than one billion
people are infected with the largest intestinal
nematode, Ascaris lumbricoides. Although there
is usually no overt clinical sign of infection,
disease can arise from an overwhelming infection
or an inappropriate immune response. Addition-
ally, infected persons frequently harbor more
than one parasite for years. Most intestinal
helminth parasites have direct life cycles, with no
intermediate host or vector, and are transferred
by contaminated food. Some species, such as
Trichuris (whipworm) and Enterobius (pinworm),
are restricted to the gut, but others, such as
Ascaris, have tissue-migrating phases. All,
however, induce a dramatic expansion of the Th2
lymphocyte subset. It remains unclear whether
these Th2-derived responses (induction of
interleukin-4 [IL-4] and down-regulation of
IFN-g), resulting in stimulation of IgG1 and IgE
isotypes, eosinophilia, and mastocytosis are
responsible for the immune-mediated pathologic
response. Immunologic lesions may occur where
early infection is associated with a strong T-cell
proliferative response that becomes down-
regulated in established chronic disease (evidence
of a Th1 defect in the chronic disease). In
ascariasis, an allergic response generated by the
lung migratory phase (chronic immune sensitiza-
tion) can cause pneumonia and, in animal models,
spontaneous development of idiopathic bronchial
asthma. A formative influence on the response of
the immune system is the antigenic environment
during pregnancy. Children born to infected
mothers may have significantly higher suscepti-
bility to the same infection later in life (42).
Viral agents induce autoimmune disorders,
and one potential mechanism of induction is
molecular mimicry (43,44). Hepatitis A virus
infection is a well-recognized cause of acute
hepatitis with jaundice in adults. In most affected
persons, the course is usually relatively short-
lived and benign, and symptoms are usually
resolved within weeks. Occasionally, relapses
occur after initial recovery, or recovery is marked
by severe or prolonged cholestasis. However,
even in these cases recovery is usual. Chronic
sequelae of hepatitis A virus infections are rare
and poorly defined; however, several recent
studies suggest that hepatitis A virus infection
triggers the onset of (idiopathic) autoimmune
chronic active hepatitis within a genetically
predisposed subgroup. Apparently, the chronic
disorder may develop despite normal serologic
response to hepatitis A virus infection. The
triggering factors and mechanism of action
remain ill-defined; however, in the most recent
study, the authors concluded that hepatitis A
virus infection may be the precipitating event in
the pathogenesis of this disorder (45).
Metabolic activation and detoxification play a
crucial role in determining the toxic response of
humans to mycotoxin exposure. These highly
toxic secondary metabolites are produced by a
wide variety of molds including Aspergillus,
Fusarium, and Penicillium. Mycotoxins exhibit
properties of acute, subacute, and chronic
toxicities with some molecules being carcinogenic,
mutagenic, and teratogenic. Because mycotoxins
are resistant to food processing and do not
degrade at high temperatures, they enter the
human food supply (46-49).
In many cases, the relationship between
mycotoxins as the causative agent of disease in
humans is difficult to determine. Acute effects of
gastroenteritis may be easily identified; however,
chronic effects often result from ingestion of low to
moderate levels and can be difficult to recognize
(46-50). The most threatening effects of ochra-
toxin A are its nephrotoxicity and carcinogenicity.
Ochratoxin A is increasingly involved in an
endemic nephropathy, a human chronic intersti-
tial neuropathy that is usually associated with
urinary tract tumors. Aflatoxins have been
implicated in both acute and chronic liver disease
in humans; however, other organs (kidney,
spleen, pancreas) may also be affected (51). The
best studied chronic effects are those induced by
the fumonisins, zearalenone, and trichothecene
mycotoxins produced by Fusarium sp. (49).
Fumonisin levels in corn-based foods have been
statistically associated with an increased risk of
human esophageal cancer. Zearalenone is an
estrogenic mycotoxin. Ingestion by animals,
especially swine, causes hyperestrogenism with
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uterus, atrophy of ovaries and testicles, enlarge-
ment of mammary glands, and infertility. This
mycotoxin might add to the estrogen load of
humans. Human consumption of trichothecene-
contaminated foods causes acute symptoms of
headaches, chills, severe nausea, vomiting, and
visual disturbances, which may last 7 to 10 days.
Since trichothecenes modulate immune function,
over time mycotoxicosis could reduce immune
resistance to infectious diseases, facilitate tumor
growth through reduced immune function, and
cause autoimmune disease (48).
Heart and Vascular Diseases
Several foodborne pathogens have been
either directly or indirectly associated with
endocarditis and myocarditis, and any heart
damage appears to be permanent (2,52). Persons
with ankylosing spondylitis linked to enteric
pathogens as the trigger show a high incidence of
cardiac conduction abnormalities, which may be
sequelae to other seronegative arthropathies. A
possible connection between foodborne gram-
negative bacteria and atherosclerosis has been
proposed, suggesting that the bacteria gain
access to the lymphoid and general circulation
with relative frequency. Endotoxin from degrad-
ing bacteria in macrophages may act in concert
with the inflammatory factors (cytokines)
induced by endotoxin from endothelium and
smooth muscle cells. Although the process of
atherogenesis is complex and involves many
factors, the hypothesis is attractive and provides
a model system for further study. Oxidative
stress responses by E. coli and S. Typhimurium
and the induction of the peroxide stimulon and
the superoxide stimulon have also been recently
implicated in atherosclerosis, rheumatoid arthri-
tis, and inflammatory bowel disease (53).
Nutritional and Gastrointestinal
Disturbances
Enteric pathogen-induced diarrhea may lead
to a variety of conditions including loss of fluids,
anorexia, and malabsorption of nutrients, all
forms of malnutrition. The enteric pathogens that
cause malabsorption and nutrient loss vary and
include Enterobacteriaceae, Rotavirus, Amoeba,
Cryptosporidium, and Giardia (2,54-58). Unless
treated with antimicrobial drugs, many diarrheal
episodes become chronic; however, the stress of
even short periods of diarrhea may result in
subtle changes in immunologic status. The extent
of the diseases depends mostly on the immune
status of the person and may last for several
years or for life. Death due to diarrheal illness in
the immunosuppressed and in persons with
AIDS is nearly 80%. No effective treatment is
available, although treatment with several
antibiotics in combination shows promising
results. However, AIDS patients may also
develop further sequelae. Cryptosporidium are
host-adapted, which may lead to pulmonary or
tracheal cryptosporidiosis accompanied by cough-
ing and frequent low-grade fever. In these cases
there is no effective treatment. Similarly, in
cyclosporidiosis, AIDS patients’ enteric infection
is chronic. Long-term prophylaxis with
trimoxazole is required, and discontinuation of
the treatment causes severe relapse (2,54-58).
Severe cases of diarrhea lasting months or
years and characterized by dysentery, with foul-
smelling, mucous bloody stools accompanied by
flatulence and abdominal distention, may result
from  C. jejuni, Citrobacter, Enterobacter, or
Klebsiella enteric infections. These infections
always require extensive antibiotic therapy and
usually result in failure to thrive. Enteric
infections may alter bowel permeability which
allows absorption of otherwise excluded food
components. Proteins that can modulate the
immune system can be absorbed possibly with
deleterious consequences such as the induction of
autoimmunity and atopy. Several studies of both
human and porcine models indicate that
significant quantities of unwanted proteins can be
absorbed by damaged gut tissue and that
maximum expression of diarrhea corresponds
with peak protein uptake (2).
Helicobacter pylori is the undisputed cause of
chronic gastritis. Environmental sources indicate
that H. pylori can survive in water, chilled foods,
milk, and fresh vegetables for several days
because of fecal contamination. The species has
never been isolated from these sources; however,
infectious, viable but nonculturable (nonspiral
coccoid) bodies may survive in fresh water for
more than a year. H. pylori can be found in human
feces and can be transmitted directly from person
to person by the fecal-oral or oral-oral route. H.
pylori can be found in several animal reservoirs;
however, the possibility of animal-to-animal or
zoonotic transmission is unknown (59,60).
Ingestion of H. pylori leads to acute gastritis, and
colonization of the stomach is virtually always
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disappears within 6 to 12 months after
eradication of the infection. Infections are
generally acquired during childhood or adoles-
cence and result in chronic gastritis lasting for
decades or life. On the basis of histologic and
serologic follow-up studies, this chronic gastritis
has been suggested as an important risk factor
(odds ratio 9.0; p = 0.001) or first stage in a
multistep process leading to gastric mucosal
atrophy, intestinal metaplasia, and eventually
gastric cancer (61,62).
Chronic Sequelae and Personality
Changes
One area that has received scant interest is
the effect of a chronic infection on human
personality factors. Personality changes might be
predicted: continual pain from arthritis, an
irritable bowel, or chronic diarrhea would be
enough to make anyone temperamental, moody,
or depressed. Studies using Cattell’s 16 Personal-
ity Factor questionnaire showed highly signifi-
cant correlations (p < 0.01 - 0.002) between
chronic toxoplasmosis and several personality
factors (63,64). Men and women showed distinct
differences in behavioral states. For men, low
superego strength, protension, guilt-proneness,
and group dependency were positively associated,
whereas in women the related factors were
affectothymia, alexia, untroubled adequacy, and
self-sufficiency. A correlation of the intensity of
the personality factor-shifts with the duration of
the infection suggested that the infection per se
induced the shift in personality, not vice versa.
An exploratory study using the 16 Person-
ality Factor questionnaire and the Holmes and
Rahe Social Readjustment Rating Scale, which
measures stressful life events, was made of
patients with rheumatoid arthritis (65). As a
group, patients with rheumatoid arthritis
exhibited higher stress at disease onset (p <
0.01); a large high-stress-at-onset subgroup of
rheumatoid arthritis patients had a worse
prognosis. Although there were important
personality changes in the high-stress-at-
onset-rheumatoid arthritis patients, the study
concluded that the interaction between the
variables that determined personality changes
were very complex and could not simply be
referred to as the “rheumatoid arthritis
personality” complex.
Conclusion
Foodborne diseases are for the most part
preventable; however, there is an inherent risk
associated with the consumption of certain types
of uncooked foods. Recognition by the public
health community and the public that many
foodborne illnesses may have serious chronic
sequelae would help eliminate many illnesses and
reduce health-care cost. Public health authorities
could make a substantial impact by reducing poor
or unhygienic food production or food-handling
practices and by educating the public about how
harmful microorganisms enter the food chain and
how they can be avoided.
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